No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan

D. Focosi, L. Macera, E. Ciabatti, S. Galimberti, M. Petrini, A. M. Carella, M. Pistello, L. Ceccherini-Nelli, F. Maggi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1065-1066
Number of pages2
Issue number6
Publication statusPublished - Dec 1 2014

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this